Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Amarantus Bioscience Holdi AMBS
Posted On: 07/02/2016 7:19:00 PM
Post# of 30070
Avatar
Posted By: longboardsurfer90210
Does not any of this sound suspect to anyone? I know we all want to believe, but really...."retraining"?

On June ?27, 2016, the Company’s contract manufacturer for its Engineered Skin Substitute ("ESS" or "Permaderm(tm)" program notified the Company’s management of the need to perform retraining of key personnel prior to opening the Phase 2 clinical study with the U.S. Army. The retraining is expected to take approximately 3-5 weeks.

And then...... possible joint venture with someone expected to happen right around the same time?

entered into a non-binding Letter of Intent (the "LOI)? with a commercial-stage wound-care company to form a joint venture (the "JV" for the further development of the Permaderm program. Under the terms of the LOI, the parties have exclusivity of negotiations for a period 30 days to enter into definitive agreements as it relates to the JV (the "Exclusivity Period". The Exclusivity Period may be extended upon mutual consent of the parties.

Yes, I am sure it is part of my "AMBS antenna" picking up on signals from the past, but at this point, this sure sounds fishy to me..... as does everything they report now a days.













(1)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site